Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
chlorpheniraminmaleat 4 mg + phenylephrinhydrochlorid 20 mg + phenyltoloxamincitrat 50 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
chlorpheniraminmaleat + phenylephrinhydrochlorid + phenyltoloxamincitrat 2,5 mg/5 ml 5 mg/5 ml 7,5 mg/5 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
paracetamol 500 mg + chlorpheniraminmaleat 8 mg + phenylephrinhydrochlorid 40 mg kapselformet tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
chlorpheniraminmaleat 2 mg + hydrocodonbitartrat 2,5 mg + phenylephrinhydrochlorid 5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
chlorpheniraminmaleat 8 mg + methscopolaminnitrat 2,5 mg + pseudoephedrinhydrochlorid 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
chlorpheniraminmaleat + phenylephrinhydrochlorid + phenyltoloxamincitrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
acetaminophen+ chlorpheniraminmaleat + phenylephrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
chlorpheniraminmaleat + methscopolaminnitrat + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
chlorpheniraminmaleat + hydrocodonbitartrat + phenylephrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
Chlorpheniramine maleate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
Chlorpheniramine maleate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
Chlorphenamine maleate 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
Product containing precisely chlorphenamine maleate 8 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
chlorpheniraminmaleat 10 mg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
Chlorphenamine maleate 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Chlorphenamine maleate 8 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine maleate 8 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine maleate 8 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
2 |
Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
3 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
3 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
4 |
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
|
Product containing precisely chlorphenamine maleate 8 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
2 |
Chlorphenamine maleate 8 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
4 |
Chlorphenamine maleate 400 microgram/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Chlorphenamine maleate 400 microgram/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine maleate 10 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine maleate 10 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Chlorphenamine maleate 10 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Chlorphenamine maleate 10 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine maleate 4 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine maleate 4 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
3 |
Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorphenamine maleate |
Inferred relationship |
Some |
3 |